<DOC>
	<DOCNO>NCT01617798</DOCNO>
	<brief_summary>Patients mechanical ventilation intensive care unit often require diursis part pre-extubation regimen . The drug choice diuresis traditionally furosemide . However , drug cause hypernatremia ( rise serum sodium ) significant proportion patient . Hypernatremia traditionally treat provide free water supplementation patient . This strategy create vicious unproductive cycle give free water , diuresing . We propose strategy break cycle use second diuretic -- metolazone -- tendency rid body sodium , thereby minimize hypernatremia .</brief_summary>
	<brief_title>Stop Hypernatremia , Use Metolazone , Aggressive , Controlled , Effective Diuresis</brief_title>
	<detailed_description>Mechanical ventilation mainstay Intensive Care . Weaning mechanical ventilation remain significant issue Intensive Care Unit ( ICU ) care worldwide . It well establish strategy diuresis negative fluid balance shorten duration mechanical ventilation acute lung injury cardiogenic pulmonary edema patient . Despite publication least one formalize complex evidence-based conservative fluid strategy , practical , uniformly implement protocol set achieve volume status target . The default approach many hospital involve use ad hoc dose ( either intermittent continuous ) loop diuretic ( usually furosemide ) instruction monitor fluid balance follow electrolytes attempt reach arbitrary target volume diuresis . Moreover , barrier achieve particular target , include pre-existing renal failure/diuretic resistance , diuretic-induced creatinine elevation , acquire diuretic resistance , hypotension volume loss , electrolyte derangement include hypokalemia hypernatremia . Strategies exist prevent treat complication presently accept standard prevent treat diuretic-induced hypernatremia . In fact , standard current intervention replace free water deficit may induce loop diuretic , simultaneously perpetuate free water deficit continue administer causative loop diuretic . This approach circular effectuate desire negative fluid balance . We address lack accepted prevention strategy use randomize controlled clinical trial ICU patient follow specific aim : 1 . Conduct randomize , pilot trial standard versus metolazone supplement diuresis ICU patient primary outcome improve negative fluid balance . 2 . Assess secondary outcome include time extubation , exacerbation renal failure , incidence electrolyte derrangements treatment control arm . 3 . Track whether initial hypernatremia within control group risk factor poor diuresis furosemide , whether delay extubation . The anticipated benefit propose intervention involve fundamental ICU patient care quality measure : avoid pitfall hypernatremia diuretic resistance lead effective diuresis , turn lead negative fluid balance , early liberation ventilator , short length stay ICU .</detailed_description>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Hypernatremia</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<mesh_term>Metolazone</mesh_term>
	<criteria>ICU patient intubate slated diuresis anticipation extubation . Patients must hypernatremic ( Na &gt; 140 mEq/L ) time diuresis initiate become hypernatremic course receive loop diuretic anticipation extubation . GFR &gt; 30 ml/min [ calculate MedCalc MDRD formula { GFR = 170 x PCr 0.999 x Age 0.176 x BUN 0.170 x Albumin0.318 x 0.762 ( woman ) x 1.180 ( black ) } ] History allergy furosemide thiazide diuretic Inability place enteral access Moribund status</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>